Peroxisomal Disorders

These are a group of inherited diseases that affect how your body breaks down certain substances. The body uses tiny parts called peroxisomes to do this job. In these disorders, peroxisomes don't work properly or are missing. This can cause a variety of problems, including learning difficulties, vision problems, and problems with the nervous system. There are different types, and symptoms can vary greatly.

Condition

What people with Peroxisomal Disorders report

Every report comes from a Lived member, sent anonymously.

Have you tried Cholic Acid for Peroxisomal Disorders?

NameHow it went

About Peroxisomal Disorders

What It Is

Peroxisomal disorders are a group of rare inherited conditions in which peroxisomes, tiny compartments found in nearly every cell, are missing or do not work properly. Peroxisomes break down certain fats, including very long chain fatty acids, and help make substances the body depends on, such as specialized fats used in the brain and nerves and the bile acids that help digest dietary fat. When these jobs fail, the brain, nerves, liver, adrenal glands, eyes, ears and bones can all be affected. The name is an umbrella rather than a single disease. In some disorders, peroxisomes are not built properly, so many of their functions fail at once. The main example is Zellweger spectrum disorder, which ranges from a severe form in newborns to milder forms that progress more slowly. The older names Zellweger syndrome, neonatal adrenoleukodystrophy and infantile Refsum disease once described separate conditions; they are now understood as severe, intermediate and mild points on that one spectrum. Rhizomelic chondrodysplasia punctata, which mainly affects bone growth, the eyes and development, also belongs to this group. Other disorders involve a single peroxisomal job. The best known is X-linked adrenoleukodystrophy (ALD), which can damage the brain's white matter (the nerve pathways that connect brain regions), the spinal cord and the adrenal glands. Adult Refsum disease, in which a fat from food called phytanic acid builds up, is another. Because the group is so varied, the specific diagnosis matters far more than the umbrella label: it shapes the likely course, the monitoring needed and which treatments are available.

Causes & Risk Factors

Peroxisomal disorders are genetic. They are not caused by anything a parent or affected person did. For some types, though, outside factors can influence how much harm the condition does, such as how much phytanic acid a person with Refsum disease eats. Zellweger spectrum disorder, rhizomelic chondrodysplasia punctata and adult Refsum disease are autosomal recessive: a person is affected when both copies of the responsible gene carry a change, one inherited from each parent. Parents who each carry one changed copy usually have no symptoms, so a diagnosis often comes without any family history. Zellweger spectrum disorder can result from changes in any of more than a dozen PEX genes, which carry the instructions for building peroxisomes. In North America, about 1 in 50,000 babies is born with one of these peroxisome-building disorders. The particular gene changes can hint at severity, but people with similar changes can still differ. X-linked ALD is inherited differently. It is caused by changes in the ABCD1 gene on the X chromosome. Boys and men with the gene change are at risk of all of its main effects. Women with the gene change usually have no symptoms in childhood, but most develop spinal cord symptoms as adults, while brain involvement and adrenal failure are extremely rare in women. Severe head injury has been reported as a possible trigger for brain involvement in males with ALD, although this has not been proven.

How It's Diagnosed

A peroxisomal disorder may be suspected in a newborn with very weak muscle tone, feeding difficulty and seizures; in a child with hearing or vision loss, developmental delay or liver problems; in a boy whose attention, behavior or schoolwork begins to slip; or in an adult with gradually increasing stiffness and weakness in the legs. Some babies are now identified before any symptoms appear: in places that screen newborns for X-linked ALD, the same test also flags most babies with Zellweger spectrum disorder. The usual first test is a blood test for very long chain fatty acids, which build up when peroxisomes cannot break them down. Because different disorders disturb different peroxisomal jobs, specialists usually also measure other substances in blood or urine, such as phytanic acid, plasmalogens (fats that peroxisomes help make) and bile acid precursors. A normal fatty acid result does not rule everything out. A few people with Zellweger spectrum disorder show little or no rise, and the standard test misses about 15% of women with ALD, so a more sensitive blood marker or genetic testing is used for them. Genetic testing confirms the exact disorder, can give clues about severity and identifies relatives who carry the same gene change. Brain MRI shows whether the white matter is affected; in boys and men with ALD it is the key test for catching brain involvement, often before symptoms appear. Hearing, vision, liver and adrenal hormone tests show which other parts of the body are involved. Once a family's gene changes are known, testing during pregnancy or of embryos during IVF is possible.

Treatment Options

For most peroxisomal disorders, no treatment restores normal peroxisome function, so care focuses on treating each problem the condition causes and protecting abilities for as long as possible. In a few situations, specific treatments can change the course. For Zellweger spectrum disorder, care is supportive and coordinated across several specialists. Seizure medicines, feeding therapy and sometimes a feeding tube placed into the stomach (a gastrostomy) address seizures and nutrition. Vitamins A, D, E and K are supplemented because poor bile acid production limits how well these vitamins are absorbed. Cholic acid (Cholbam), a bile acid taken as a capsule, is FDA approved as an add-on treatment for people with peroxisomal disorders who have liver disease, fatty stools or problems from poor vitamin absorption; its benefit outside the liver and digestion has not been shown. Hearing aids or cochlear implants, glasses, and early physical, occupational and speech therapy support communication and development. No specific diet is recommended, and DHA, a fish-oil fat that was once commonly given, showed no clinical benefit in a placebo-controlled study. For X-linked ALD, the most important treatment decision concerns the brain. When regular MRI scans catch early, active brain involvement, a stem cell transplant from a donor (allogeneic hematopoietic cell transplant) can halt its progression; results are poor once brain disease is advanced, which is why surveillance matters so much. For boys aged 4 to 17 with early, active brain disease and no matched donor, a gene therapy made from the boy's own stem cells, elivaldogene autotemcel (Skysona), is FDA approved to slow neurologic decline. It has caused blood cancers in some treated boys, so it requires long-term monitoring, and the timing of treatment is weighed carefully. Neither treatment is expected to correct adrenal insufficiency (when the adrenal glands do not make enough of the hormone cortisol) or the spinal cord symptoms of adulthood. Adrenal insufficiency is treated with daily steroid hormone replacement guided by an endocrinologist. Leg stiffness and nerve pain from spinal cord involvement are treated with medicines such as baclofen, a muscle relaxant, and gabapentin or pregabalin for nerve pain, along with rehabilitation. Lorenzo's oil, a mixture of two dietary oils taken by mouth, lowers blood fatty acid levels, but it has not been shown to change the course of ALD. For adult Refsum disease, a lifelong diet low in phytanic acid, which comes mainly from beef and dairy fats, is the main treatment, and starting it before more organ damage occurs offers the best outlook.

What to Expect

The outlook depends heavily on which disorder a person has and where they fall within it. Babies with the severe form of Zellweger spectrum disorder have brain and organ differences that begin before birth, and they usually do not survive beyond the first year; care then centers on seizure control, feeding and breathing support, and the family's goals. In the intermediate and milder forms, symptoms often appear in late infancy or childhood and progress more slowly. Many children live into later childhood, and some into adulthood, with varying degrees of hearing and vision loss, developmental delay and liver problems; some have normal intelligence. Rhizomelic chondrodysplasia punctata usually causes severe disability, and it is rare for children to live past age 10. X-linked ALD is hard to predict, even within one family. The brain form most often begins in boys between about 4 and 10 but can start at any age, and without early treatment it can lead to severe disability within a few years. Adrenal failure can appear from infancy onward. Virtually all men and most women with ALD eventually develop spinal cord symptoms such as leg stiffness, weakness, balance problems and bladder changes, usually starting in adulthood and progressing slowly. Because of this uncertainty, surveillance is central to daily life: boys typically have a brain MRI every 6 months between ages 2 and 12 and yearly afterward, along with regular adrenal blood tests. For most of these conditions, care involves a team, often including a metabolic or genetics specialist, neurologist, endocrinologist, eye and hearing specialists and therapists, with checkups at least yearly. Early intervention services and school support help children reach their potential, and families of children with both hearing and vision loss can connect with deaf-blind support programs. Genetic counseling helps families understand the chances for future children and which relatives may benefit from testing.

When to Seek Help

Ask about an evaluation by a genetics or metabolic specialist if a child has unexplained hearing or vision loss, developmental delay with weak muscle tone, or liver problems, if an adult develops gradually worsening stiffness and weakness in the legs, or if a relative has been diagnosed with a peroxisomal disorder such as ALD. For a boy or man with ALD, contact the care team promptly about new problems with attention, learning or behavior, changes in speech, vision or hearing, or worsening walking or coordination, since these can signal brain involvement and an MRI should be done as soon as possible. Also contact them promptly about ongoing tiredness, weight loss, darkening skin or nausea, which can point to adrenal insufficiency in anyone with ALD or Zellweger spectrum disorder. Adrenal crisis is an emergency. In someone with known or suspected adrenal insufficiency, severe weakness, severe belly pain, repeated vomiting, confusion or fainting needs emergency care: call 911. Anyone taking steroid replacement should have a written stress-dose plan from their endocrinologist, which raises the steroid dose during serious illness, fever or surgery. If they cannot keep their steroid medicine down, they need the emergency hydrocortisone injection if one has been prescribed and urgent medical care the same day.

Questions to Ask Your Doctor

  1. 1.Which specific peroxisomal disorder is this, and what do the genetic results suggest about how it may progress?
  2. 2.Which parts of the body need regular checking, how often, and who will coordinate that care?
  3. 3.Is there adrenal insufficiency now or a risk of it, and what is our stress-dose plan during illness or surgery?
  4. 4.If MRI shows early brain changes from ALD, would a transplant or gene therapy be an option, and what are the trade-offs?
  5. 5.Which relatives should be offered testing, and what options are there for future pregnancies?

Last reviewed • Oct 2026

Educational content, not medical advice.